- $33.71bn
- $33.53bn
- $13.06bn
- 82
- 29
- 75
- 65
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 6-K |
Standards: | USG | USG | USG | USG | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,175 | 4,376 | 9,955 | 12,450 | 13,064 |
Cost of Revenue | |||||
Gross Profit | 605 | 1,349 | 3,896 | 5,185 | 5,834 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,067 | 5,703 | 11,540 | 13,738 | 12,800 |
Operating Profit | -891 | -1,328 | -1,585 | -1,288 | 263 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -1,369 | -1,483 | -1,715 | -1,501 | 432 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1,454 | -1,625 | -2,048 | -1,669 | 170 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -1,463 | -1,618 | -2,047 | -1,651 | 151 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1,463 | -1,618 | -2,047 | -1,651 | 151 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -3.35 | -3.34 | -3.84 | -2.78 | 0.34 |